- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04800549
Effect of Black Mulberry Lollipop on Prevention of Oral Mucositis in Children
March 12, 2021 updated by: ebru kaya, Sapanca Ilce Devlet Hastanesi
The Effect of Black Mulberry Lollipop and Sodium Bicarbonate Used in Oral Care on Prevention of Oral Mucositis Among Children Receiving Chemotherapy Due to Cancer
THE EFFECT OF BLACK MULBERRY LOLLIPOP AND SODIUM BICARBONATE USED IN ORAL CARE ON PREVENTION OF ORAL MUCOSITIS AMONG CHILDREN RECEIVING CHEMOTHERAPY DUE TO CANCER
Study Overview
Detailed Description
The study was conducted experimentally to determine the effect of black mulberry lollipop and sodium bicarbonate used in oral care on prevention of oral mucositis in children followed up due to the diagnosis of cancer.
Sodium bicarbonate and black mulberry treatment were compared to prevent oral mucositis in 69 children receiving chemotherapy due to cancer.
While 35 children were assigned to the experimental group (sodium bicarbonate + black mulberry lollipop application), 34 were assigned to the control group (sodium bicarbonate application).
Study Type
Interventional
Enrollment (Actual)
69
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Türkiye
-
Sakarya, Türkiye, Turkey, 54600
- Sağlık Bakanlığı Sapanca Ilçe Hastanesi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Being in the age group of 3-18 years
- Being hospitalised for chemotherapy treatment
- Not having oral mucositis
- No using another method to protect oral mucosa during the study period
- Not having the history of black mulberry (similar fruit berries, blackberries, etc.) allergy
- Not having intolerance to cold
Exclusion Criteria:
-Not having food in mouth
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: METHOD
The power of the test in the study was calculated by using G*Power 3.1 program.
While Type I error is 0.05 and the power of the test is 0.80 (α= 0.05, 1-β= 0.80), minimal sample size was calculated as 62 children (31 children in each group).
By considering the losses that may occur from the sample during the study due to any reason, it was planned to include 40 children in both experimental and control groups.
Follow-up lost occurred in 5 patients from experimental group and 6 patients in the control group during the study.
The study was completed with 69 paediatric patients including 34 in the experimental group and 35 in the control group.
|
The data of the study were obtained by conducting six interviews with each child and the family.
The first interview was conducted before starting to treatment on the first day of the treatment, the second interview was conducted on the 2nd day after the treatment and the following interviews were conducted on the 4th, 8th, 16th, and 21st days and in-mouth mucosa of the patient was evaluated by taking in-mouth pictures following interviewing with the child and the family.
Oral care application was conducted four times a day with sodium bicarbonate solution and a lollipop made with black mulberry syrup (after meals and before going to the bed at night).
Oral care was first conducted by the researcher, the oral care was then taught to the patient and patient's relatives and the application was evaluated.
Figure 1 shows the study design.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Follow-up Form
Time Frame: 3 minute
|
It has 16 questions prepared by the researcher utilising literature and including sociodemographic characteristic and oral care habits of the child and family.
|
3 minute
|
|
Children's International Mucositis Evaluation Scale
Time Frame: 2 minute
|
Tomlison et al. (2010) developed Children's International Mucositis Evaluation Scale (ChIMES) in order to evaluate the difficulty experienced by children with cancer due to mouth/throat pain developing depending on mucositis.
Yavuz et al., (2011) conducted the validity and reliability study of the Turkish version of the scale.
The scale consists of six (6) questions and it is an easy-to-apply form that can be answered with the child's facial expressions.
|
2 minute
|
|
Nurse Observation Chart of Child Mucositis Evaluation
Time Frame: 10 minute
|
It was prepared in parallel with Oral Mucositis Evaluation Index of the World Health Organization and formed to monitor formation or level of oral mucositis in children on the first, second, fourth, eights, sixteenth and twenty first days.
|
10 minute
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2016
Primary Completion (Actual)
February 1, 2017
Study Completion (Actual)
February 1, 2017
Study Registration Dates
First Submitted
December 13, 2019
First Submitted That Met QC Criteria
March 12, 2021
First Posted (Actual)
March 16, 2021
Study Record Updates
Last Update Posted (Actual)
March 16, 2021
Last Update Submitted That Met QC Criteria
March 12, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SapancaH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Mucositis
-
Instituto Nacional de Cancer, BrazilWithdrawnOral Mucositis | Oral Mucositis (Ulcerative) Due to Radiation | Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy | Oral Mucositis Due to RadiationBrazil
-
Air Force Military Medical University, ChinaCompletedMucositis OralChina
-
Ain Shams UniversityCompletedOral Mucositis | Radiation Induced Oral Mucositis | Oral Mucositis Due to RadiationEgypt
-
University Hospital, ToulouseRecruiting
-
Catalysis SLCompletedMucositis OralRussian Federation
-
Ain Shams UniversityNot yet recruitingOral Mucositis Due to ChemotherapyEgypt
-
Zubeyde Ezgi ErcelikCompleted
-
Galera Therapeutics, Inc.CompletedRadiation Induced Oral MucositisUnited States, Canada, Puerto Rico
-
Ghada zakiNot yet recruiting
-
Cairo UniversityNot yet recruitingChemotherapy Induced Oral Mucositis
Clinical Trials on Oral Mucositis
-
Fundación Pública Andaluza Progreso y SaludUnknown
-
E2Bio Life Sciences, LLCHematology Center after Prof. R. YeolyanWithdrawnOral Mucositis | Stem Cell Transplant ComplicationsArmenia
-
Trakya UniversityCompletedChemotherapy | Breast Cancer Early Stage Breast Cancer (Stage 1-3)Turkey
-
Sun Yat-sen UniversityZhejiang Cancer Hospital; Wuzhou Red Cross Hospital; Xiangya Hospital of Central... and other collaboratorsRecruitingRadiation-induced Oral Mucositis | Nasopharyngeal Cancinoma (NPC)China
-
University of Rome Tor VergataCompletedMesenchymal Stem Cells | Graft Vs Host Disease | Oral Mucositis (Ulcerative)Italy
-
Ain Shams UniversityCompleted
-
University of PittsburghEnrolling by invitationPeri-Implantitis | Peri-implant MucositisUnited States
-
The University of Texas Health Science Center at...South Texas Veterans Health Care SystemCompletedPeripheral Blood Stem Cell TransplantationUnited States
-
Hanna LahteenmakiUniversity of HelsinkiEnrolling by invitationPeri-Implantitis and Peri-implant Mucositis | Peri-Implant HealthFinland
-
St. Jude Children's Research HospitalAssociation of Pediatric Hematology Oncology NursesCompleted